Coronavirus disease 2019 in the pediatric emergency department: unique considerations in preparation and response

Suzanne Beno1, Caitlin Ross, Tania Principi

  • 1Division of Emergency Medicine, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.

Insights

Pediatric emergency departments adapted to COVID-19 by modifying operations, using personal protective equipment (PPE), and enhancing care. Despite challenges, these departments successfully prepared for pediatric patients during the pandemic.

Area of Science:

  • Pediatric Emergency Medicine
  • Infectious Disease Epidemiology
  • Public Health Response

Background:

  • The coronavirus disease 2019 (COVID-19) pandemic presented unique challenges for Pediatric Emergency Departments (PEDs).
  • Children generally experience milder COVID-19 courses but can develop conditions like multisystem inflammatory syndrome in children (MIS-C).
  • The pandemic impacted injury rates, emergency care utilization, and mental health, abuse, and neglect rates in children and youth.

Purpose of the Study:

  • To review adaptations and challenges in PEDs during the COVID-19 pandemic.
  • To focus on operational modifications, personal protective equipment (PPE) needs, resuscitation protocols, and clinical presentations in children.
  • To examine the unintended effects of the pandemic on children and youth.

Main Methods:

  • Review of adaptations and challenges in PED preparation and response.
  • Focus on operational modifications, PPE, protected resuscitation, and clinical characteristics.
  • Analysis of pandemic's effects on pediatric emergency care and child welfare.

Main Results:

  • PEDs successfully prepared for the pandemic through significant adjustments.
  • Key adaptations included enhanced screening, testing, consistent PPE use, and protected resuscitation.
  • Technological advancements in communication and virtual care were implemented, with simulation playing a crucial role.

Conclusions:

  • COVID-19 necessitated rapid adaptation in PEDs, leading to both challenges and advancements.
  • Ongoing experience and research are vital for optimizing pediatric emergency care during pandemics.
  • Future efforts should focus on clinical/operational care, training, and provider well-being.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
76
Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

Transmission-based Precautions I: Contact, Enteric, and Droplets

Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
4.2K
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.6K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
81
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
82
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
109